Brief: Radiopharm Theranostics Got U.S. FDA IND Approval For Its Αvβ6 Integrin (Rad301) Technology
Dec 30 (Reuters) - Radiopharm Theranostics Ltd RAD.AX :
* GOT U.S. FDA IND APPROVAL FOR ITS ΑVΒ6 INTEGRIN (RAD301)
TECHNOLOGY
Source text for Eikon: ID:nASX51ykFv
Further company coverage: RAD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsNASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Radiopharm Theranostics To Meet With U.S. FDA To Align On Pivotal Phase 3 Trial Design For Rad 101 In Diagnosis Of Brain Metastases
NASDAQ RESUMED AT 09:56 AM
NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:50 AM